C. Stach

4.6k citations
45 papers · 2.2k · h-index 19

Impact in

  • Rheumatology top 0.5%
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Immunology top 2%
    • Psoriasis: Treatment and Pathogenesis
    • Phagocytosis and Immune Regulation
    • T-cell and B-cell Immunology

Papers in

  • Rheumatology 34
    • Rheumatoid Arthritis Research and Therapies 20
    • Spondyloarthritis Studies and Treatments 19
    • Systemic Lupus Erythematosus Research 14
  • Immunology 22
    • Psoriasis: Treatment and Pathogenesis 9
    • Phagocytosis and Immune Regulation 5
Co-authors
Georg Schett (7 shared papers)Matthias Englbrecht (5 shared papers)Bengt Hoepken (16 shared papers)Philip J. Mease (7 shared papers)Atul Deodhar (5 shared papers)Désirée van der Heijde (11 shared papers)Klaus Engelke (4 shared papers)Reinhard Voll (6 shared papers)
Journals
Annals of the Rheumatic Diseases (20 papers)Lara D. Veeken (5 papers)The Journal of Rheumatology (2 papers)Journal of Leukocyte Biology (1 paper)The Journal of Experimental Medicine (1 paper)
Partner nations
GermanyUnited StatesUnited Kingdom

In The Last Decade

C. Stach

40 papers receiving 2.1k citations

Peers

C. Stach
Comparison fields: 5 of 100
  • Rheumatology 1.5k
  • Immunology 1.2k
  • Hematology 448
  • Orthopedics and Sports Medicine 178
  • Radiology, Nuclear Medicine and Imaging 222
Replace M. G. H. Van de Sande with:
M. G. H. Van de Sande Netherlands
Eva Dokoupilová Czechia
Serena Bugatti Italy
Herbert Kellner Germany
G. Yanni United Kingdom
So‐Young Bang South Korea
Valérie Devauchelle France
Richard Newmark United States
Alessandra Nerviani United Kingdom
Stephen Kelly United Kingdom
C. Stach relative to M. G. H. Van de Sande Netherlands M. G. H. Van de Sande's profile →
Citations per field
00.5×1.5×2×2.4×
M. G. H. Van de Sande · 1×
Citations per year

Countries citing papers authored by C. Stach

Since Specialization
Citations

This map shows the geographic impact of C. Stach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Stach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Stach more than expected).

Fields of papers citing papers by C. Stach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Stach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Stach. The network helps show where C. Stach may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Stach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Stach Line = papers co-authored together C. Stach links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)
Annals of the Rheumatic Diseases ·Philip J. Mease, Roy Fleischmann, Atul Deodhar, J. Wollenhaupt, Majed Khraishi, Danuta Kielar, Franz Woltering, C. Stach, Bengt Hoepken, T. Arledge, Désirée van der Heijde
2013360
2
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
Annals of the Rheumatic Diseases ·Robert Landewé, Jürgen Braun, Atul Deodhar, Maxime Dougados, Walter P. Maksymowych, Philip J. Mease, John D. Reveille, Martín Rudwaleit, Désirée van der Heijde, C. Stach, Bengt Hoepken, Andreas Fichtner, G. Coteur, M. de Longueville, Joachim Sieper
2013346
3
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials
Arthritis & Rheumatology ·Megan E. B. Clowse, Daniel J. Wallace, Richard Furie, Michelle Petri, Marilyn C. Pike, Piotr Leszczyński, C. Michael Neuwelt, Kathryn Hobbs, Mauro Waldemar Keiserman, Liliana Duca, Kenneth Kalunian, C. Galateanu, Sabine Bongardt, C. Stach, Carolyn Beaudot, B. Kilgallen, Caroline Gordon, (unknown)
2016169
4
Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high‐resolution computed tomography
Arthritis & Rheumatism ·C. Stach, Michael Bäuerle, Matthias Englbrecht, Gerhard Krönke, Klaus Engelke, Bernhard Manger, Georg Schett
2010145
5
Inhibition of Phosphatidylserine Recognition Heightens the Immunogenicity of Irradiated Lymphoma Cells In Vivo
The Journal of Experimental Medicine ·Attilio Bondanza, Valérie S. Zimmermann, Patrizia Rovere‐Querini, Javier Turnay, Ingrid E. Dumitriu, C. Stach, Reinhard Voll, Udo S. Gaipl, Wolf Bertling, Ernst Pöschl, Joachim R. Kalden, Angelo A. Manfredi, Martin Herrmann
2004143
6
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis
Annals of the Rheumatic Diseases ·S. Finzel, Matthias Englbrecht, Klaus Engelke, C. Stach, Georg Schett
2010114
7
Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion
Annals of the Rheumatic Diseases ·S. Finzel, Jürgen Rech, S. Schmidt, Klaus Engelke, Matthias Englbrecht, C. Stach, Georg Schett
2011106
8
A detailed comparative study of high‐resolution ultrasound and micro–computed tomography for detection of arthritic bone erosions
Arthritis & Rheumatism ·Stephanie Finzel, Sarah Ohrndorf, Matthias Englbrecht, C. Stach, Janin Messerschmidt, Georg Schett, Marina Backhaus
201196
9
How antirheumatic drugs protect joints from damage in rheumatoid arthritis
Arthritis & Rheumatism ·Georg Schett, C. Stach, Jochen Zwerina, Reinhard Voll, Bernhard Manger
200891
10
Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles
Annals of the Rheumatic Diseases ·Chris Chamberlain, Peter Colman, Ann Ranger, Linda C. Burkly, Geoffrey I. Johnston, Christian Otoul, C. Stach, Miren Zamacona, Thomas Dörner, Murray B. Urowitz, Falk Hiepe
201787
11
Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus
Lara D. Veeken ·Richard Furie, Ian N Bruce, Thomas Dörner, Manuel Gustavo Leon, Piotr Leszczyński, Murray B. Urowitz, Birgit Haier, Teri Jimenez, Claire Brittain, Jiajun Liu, Catherine Barbey, C. Stach
202179
12
Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice
Cell Death and Differentiation ·C. Stach, Javier Turnay, Reinhard Voll, P. M. Kern, Wasilis Kolowos, Thomas Beyer, J. R. Kalden, Martin Herrmann
200070
13
Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol
Annals of the Rheumatic Diseases ·D. van der Heijde, Roy Fleischmann, J. Wollenhaupt, Atul Deodhar, Danuta Kielar, Franz Woltering, C. Stach, Bengt Hoepken, T. Arledge, Philip J. Mease
201360
14
The influence on the immunomodulatory effects of dying and dead cells of Annexin V
Journal of Leukocyte Biology ·Luis E. Muñoz, Sandra Franz, Friederike Pausch, Barbara G. Fürnrohr, Ahmed Sheriff, Birgit Vogt, Peter Kern, Wolfgang Baum, C. Stach, Dorotheé von Laer, Bent Brachvogel, Ernst Pöschl, Martin Herrmann, Udo S. Gaipl
200649
15
Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal – implications for antiphospholipid syndrome and systemic lupus erythematosus
Immunobiology ·Udo S. Gaipl, Thomas Beyer, Irith Baumann, Reinhard Voll, C. Stach, Petra Heyder, Joachim R. Kalden, Angelo A. Manfredi, Martin Herrmann
200341
16
Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus
Annals of the Rheumatic Diseases ·Barbara G. Fürnrohr, Sven Wach, Jennifer A. Kelly, Martin Haslbeck, Christian K Weber, C. Stach, Axel J. Hueber, Daniela Graef, Bernd M. Spriewald, Karin Manger, Martin Herrmann, Kenneth M. Kaufman, Summer G Frank-Pearce, Ellen Goodmon, Judith A. James, Georg Schett, Thomas Winkler, John B. Harley, Reinhard Voll
201034
17
Early detection of apoptosis by staining of acid‐treated apoptotic cells with FITC‐labeled lectin from Narcissus pseudonarcissus
Cytometry Part A ·Petra Heyder, Udo S. Gaipl, Thomas Beyer, Reinhard Voll, Peter Kern, C. Stach, Joachim R. Kalden, Martin Herrmann
200334
18
Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis
RMD Open ·Jürgen Braun, Xenofon Baraliakos, Kay‐Geert Hermann, Robert Landewé, Pedro Machado, Walter P. Maksymowych, O. Davies, Bengt Hoepken, T. Nurminen, C. Stach, Désirée van der Heijde
201729
19
FRI0195 EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL (DZP) IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A RANDOMISED, PLACEBO (PBO)-CONTROLLED STUDY
Annals of the Rheumatic Diseases ·Richard Furie, Ian N Bruce, Thomas Dörner, Manuel Gustavo Leon, Piotr Leszczyński, Murray B. Urowitz, Birgit Haier, Teri Jimenez, Catherine Barbey, Jiajun Liu, C. Stach
201921
20
210. Effect of Certolizumab Pegol Over 48 Weeks on Signs and Symptoms in Patients with Psoriatic Arthritis with and Without Prior Tumor Necrosis Factor Inhibitor Exposure
Lara D. Veeken ·Philip J. Mease, R. Fleischmann, J. Wollenhaupt, Atul Deodhar, Dafna D. Gladman, C. Stach, Bengt Hoepken, Luke Peterson, Désirée van der Heijde
201414

About C. Stach

C. Stach is a scholar working on Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Orthopedics and Sports Medicine and Molecular Biology, having authored 45 papers that have together received 2.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (20 papers), Spondyloarthritis Studies and Treatments (19 papers), Systemic Lupus Erythematosus Research (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Psoriasis: Treatment and Pathogenesis (9 papers), Bone and Joint Diseases (6 papers), Phagocytosis and Immune Regulation (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Rheumatology (1.5k citations), Immunology (1.2k citations), Hematology (448 citations), Orthopedics and Sports Medicine (178 citations) and Radiology, Nuclear Medicine and Imaging (222 citations). C. Stach has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Georg Schett, Matthias Englbrecht, Bengt Hoepken, Philip J. Mease, Atul Deodhar, Désirée van der Heijde, Klaus Engelke, Reinhard Voll, Danuta Kielar and J. Wollenhaupt. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, The Journal of Rheumatology, Journal of Leukocyte Biology and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. G. H. Van de SandeBreakdown of academic impact, for papers by Eva DokoupilováBreakdown of academic impact, for papers by Serena BugattiBreakdown of academic impact, for papers by Herbert KellnerBreakdown of academic impact, for papers by G. YanniBreakdown of academic impact, for papers by So‐Young BangBreakdown of academic impact, for papers by Valérie DevauchelleBreakdown of academic impact, for papers by Richard NewmarkBreakdown of academic impact, for papers by Alessandra NervianiBreakdown of academic impact, for papers by Stephen Kelly